New Data Show Positive Impact of Oncotype DX® on Patient Care
Exact Sciences, a leading provider of cancer screening and diagnostic tests, announced the presentation of new data further reinforcing the utility of its Oncotype DX...
Tag : breast cancer
OS Therapies Gets Patent Allowance for OST-HER2 Manufacturing
Patent Term Adjustment will provide market exclusivity in the United States into 2040 for all therapeutic indications OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology...